Document Detail

Inhibition of platelet aggregation by the GPIIb/IIIa antagonist reopro does not significantly prolong xenograft survival in an ex vivo model.
MedLine Citation:
PMID:  10551997     Owner:  NLM     Status:  MEDLINE    
Effects on hyperacute rejection were studied in a discordant model with the platelet GPIIb/IIIa antagonist Reopro. Pig kidneys perfused with human blood survived median 118 min in the Reopro group and 103 min in the controls (P = 0.22). Platelet and leukocyte counts decreased, whereas plasma thrombospondin and soluble as well as platelet membrane P-selectin increased significantly in both groups without significant intergroup differences. beta-Thromboglobulin and myeloperoxidase increased significantly more in the control group than in the Reopro group (P = 0.009 and P = 0.02, respectively). The classical complement pathway was substantially and similarly activated in both groups. Light and electron microscopy revealed arterial thrombi and numerous glomerular platelet aggregates in the control group in contrast to the Reopro group. In conclusion, Reopro reduced platelet aggregation, and platelet and leukocyte activation to some extent, but had no effect on complement activation and did not significantly prolong xenograft survival, even though better preservation of morphology was shown.
A E Fiane; V Videm; T E Mollnes; K Høgâsen; T Hovig
Related Documents :
24839367 - Prophyactic platelet transfusion in stable dengue fever patients: is it really necessary?
3375287 - Platelet aggregation and thromboxane a2 release in primary biliary cirrhosis and effect...
15771927 - Postmenopausal hormone replacement therapy increases plasmatic thromboxane beta 2.
2974487 - Desensitization of platelet thromboxane a2/prostaglandin h2 receptors by the mimetic u4...
1450317 - Effect of thrombin inhibitors on platelet functions: comparative analysis of dup 714 an...
9568527 - Toxicity of ornidazole and its analogues to rat spermatozoa as reflected in motility pa...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Transplant international : official journal of the European Society for Organ Transplantation     Volume:  12     ISSN:  0934-0874     ISO Abbreviation:  Transpl. Int.     Publication Date:  1999  
Date Detail:
Created Date:  1999-11-30     Completed Date:  1999-11-30     Revised Date:  2013-05-24    
Medline Journal Info:
Nlm Unique ID:  8908516     Medline TA:  Transpl Int     Country:  GERMANY    
Other Details:
Languages:  eng     Pagination:  323-33     Citation Subset:  IM    
Department of Surgery A, University of Oslo, The National Hospital, Pilestredet 32, N-0027 Oslo, Norway.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies, Monoclonal / pharmacology*
Graft Rejection
Graft Survival / drug effects*
Immunoglobulin Fab Fragments / pharmacology*
Platelet Aggregation / drug effects*
Platelet Aggregation Inhibitors / pharmacology*
Platelet Count
Platelet Glycoprotein GPIIb-IIIa Complex / antagonists & inhibitors*
Transplantation, Heterologous / immunology*
Reg. No./Substance:
0/Antibodies, Monoclonal; 0/Immunoglobulin Fab Fragments; 0/Platelet Aggregation Inhibitors; 0/Platelet Glycoprotein GPIIb-IIIa Complex; X85G7936GV/abciximab

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Influence of tacrolimus on bile acid and lipid composition in continuously drained bile using a rat ...
Next Document:  Ureteral stenosis after kidney transplantation. A study on 869 consecutive transplants.